I am a
Home I AM A Search Login

Papers of the Week

2022 Jun 27

Clin Neurol Neurosurg


Calcitonin gene-related peptide and neurologic injury: An emerging target for headache management.


Mehkri Y, Hanna C, Sriram S, Lucke-Wold B, Johnson RD, Busl K
Clin Neurol Neurosurg. 2022 Jun 27; 220:107355.
PMID: 35785661.


Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide known to be involved in the trigeminovascular system and to function as a potent vasodilator. Although it has emerged as a viable target for headache management with targeted treatments developed for migraine, a highly disabling neurovascular disorder, less is known about CGRP's role in other neurologic conditions such as traumatic brain injury and subarachnoid hemorrhage. The literature has shown that during these injury cascades, CGRP receptors are modulated in varying ways. Therefore, CGRP or its receptors might be viable targets to manage secondary injuries following acute brain injury. In this review, we highlight the pathophysiology of the CGRP pathway and its relation to migraine pathogenesis. Using these same principles, we assess the existing preclinical data for CGRP and its role in acute brain injury. The findings are promising, and set the basis for further work, with specific focus on the therapeutic benefit of CGRP modulation following neurologic injury.